John Wiley & Sons Inc
F:2F70

Watchlist Manager
John Wiley & Sons Inc Logo
John Wiley & Sons Inc
F:2F70
Watchlist
Price: 33.6 EUR -2.89% Market Closed
Market Cap: €1.8B

John Wiley & Sons Inc
Investor Relations

John Wiley & Sons is a publishing company that makes books, journals, digital learning tools, and research platforms. Its core business is serving people who need trusted information for school, work, and professional development, especially in science, medicine, engineering, business, and higher education. It sells directly to readers and institutions, and it also licenses access to its digital content through subscriptions and online platforms. Wiley makes money in a few main ways: selling textbooks and professional books, charging libraries and universities for journal access, and selling digital courses and learning services to schools, companies, and individual learners. A large part of its business comes from recurring access fees rather than one-time book sales, which helps make its revenue model more stable than a traditional publisher’s. What sets Wiley apart is its role as a trusted middleman between authors, researchers, educators, and end users. It does not just print books; it curates and packages expert content, then distributes it in formats that schools, researchers, and professionals can use every day. That makes it a key supplier of specialized knowledge rather than a general consumer publisher.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2026
Call Date
Mar 5, 2026
AI Summary
Q3 2026

Quarter result: Q3 was in line with expectations — revenue essentially flat at constant currency, with Research strength offsetting softness in Learning.

Research momentum: Research publishing outpaced the market — submissions up 26%, global output up 11%, and publishing revenue up 4% excluding AI.

AI ramp: AI and data revenue is accelerating — $42 million year-to-date, $7 million recognized in the quarter, and company guidance of $45–$50 million for fiscal '26.

Margins & cash: Continued margin expansion and cash generation — adjusted operating margin up 280 bps in the quarter, adjusted EBITDA margin up 250 bps, and operating cash flow nearly doubled to $103 million.

Cost & transformation: Tech transformation and outsourcing (Virtusa) are driving corporate cost savings (corporate costs down 21% this quarter on an adjusted EBITDA basis) and expected further margin benefits.

Capital returns: Buybacks stepping up — $70 million repurchased year-to-date, $100 million full-year target; $126 million returned in dividends and buybacks in nine months.

Outlook: Raising margin and EPS guidance to the high end of prior ranges; revenue growth expected low single-digits and free cash flow reaffirmed at ~ $200 million.

Key Financials
Revenue (company-wide, Q3)
up 1% reported, flat at constant currency
Research (Q3)
up 1%
Research Publishing (ex-AI)
up 4%
Submissions
up 26%
Global output
up 11%
AI revenue (quarter)
$7 million
AI revenue (year-to-date)
$42 million
AI revenue (fiscal '25)
$40 million
AI revenue (fiscal '24)
$23 million
Adjusted operating margin (Q3)
up 280 basis points
Adjusted EBITDA margin (Q3)
up 250 basis points
Adjusted operating income
up 22%
Adjusted EPS (Q3)
up 19%
Adjusted EBITDA (Q3)
up 12%
Operating cash flow (Q3)
$103 million
Free cash flow (guidance)
approximately $200 million
CapEx (prior year)
$77 million
Corporate expense (adjusted EBITDA basis)
down 21% in the quarter, down 12% year-to-date
Total returned to shareholders (9 months)
$126 million
Leverage (net debt / EBITDA)
1.7 (down from 2.0)
Advanced portfolio revenue (fiscal '26)
will exceed $70 million
Clinical Outcome Assessments (COA) catalog
nearly 7 million (vs 800,000 in 2021)
Gateway registrations
9,000 researchers registered
Virtusa contract size
roughly $150 million over 5 years
Dividend yield
approximately 4.5%
Earnings Call Recording
Other Earnings Calls

Management

Mr. Jesse Caleb Wiley
Non-Executive Chairman
No Bio Available
Mr. Matthew S. Kissner
President, CEO & Employee Director
No Bio Available
Ms. Danielle McMahan
Executive VP & Chief People Officer
No Bio Available
Mr. James Flynn
Executive VP and GM of Research & Learning
No Bio Available
Mr. Christopher F. Caridi
Interim CFO, Senior VP, Chief Accounting Officer & Global Corporate Controller
No Bio Available
Mr. Brian Campbell
Vice President, Investor Relations
No Bio Available
Mr. Josh Jarrett
Senior Vice President of Strategy
No Bio Available

Contacts

Address
NEW JERSEY
Hoboken
111 River St
Contacts
+12017486000.0
www.wiley.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett